GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
137.10
-0.37 (-0.27%)
Oct 29, 2025, 1:17 PM EDT - Market open
GeneDx Holdings Employees
GeneDx Holdings had 1,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$402,190
Profits / Employee
$2,083
Market Cap
3.96B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000 | 0 | - |
| Dec 31, 2023 | 1,000 | -100 | -9.09% |
| Dec 31, 2022 | 1,100 | -100 | -8.33% |
| Dec 31, 2021 | 1,200 | 328 | 37.61% |
| Dec 31, 2020 | 872 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
WGS News
- 21 hours ago - GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights - Business Wire
- 2 days ago - GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth - Seeking Alpha
- 2 days ago - GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims - PRNewsWire
- 5 days ago - Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 7 days ago - GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025 - Business Wire
- 9 days ago - GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing - Business Wire
- 14 days ago - Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot - PRNewsWire